Cipla reported INR62.19B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
aTyr Pharma USD 296.74M 295.7M Dec/2025
Brainstorm Cell Therapeutics USD 86K 6K Dec/2025
Capricor Therapeutics USD 59K 0 Dec/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cipla INR 62.19B 12.42B Mar/2026
Dr.Reddys Laboratories INR 104.74B 563M Mar/2026
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Immunic USD 333K 156K Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Sun Pharmaceuticals INR 162.09B 5.05B Mar/2026
TherapeuticsMD USD 2.91M 310K Jun/2024
UPL INR 194.58B 19.13B Mar/2026